General Information of Drug (ID: DM5ZTE4)

Drug Name
PRO-001 Drug Info
Synonyms PRO-001, ProRetina; Proinsulin (recombinant human protein, retinitis pigmentosa), ProRetina
Indication
Disease Entry ICD 11 Status REF
Retinitis pigmentosa 9B70 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DM5ZTE4

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Bacitracin DM5OHYE Blepharoconjunctivitis Approved [3]
GNF-PF-4478 DMCDU8K Discovery agent N.A. Investigative [4]
quinoline 2 DM1QIPZ Discovery agent N.A. Investigative [5]
NTE-2 DM4DB0W Discovery agent N.A. Investigative [5]
NTE-1 DMFIE0U Discovery agent N.A. Investigative [5]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Insulin-degrading enzyme (IDE) TT2EDHU IDE_HUMAN Modulator [2]

References

1 ClinicalTrials.gov (NCT02520583) The Effects of Probiotic Supplementation on Markers of Muscle Damage and Performance Following Exercise Induced Muscle Damage.
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2371).
3 Brain insulin impairs amyloid-beta(1-40) clearance from the brain. J Neurosci. 2004 Oct 27;24(43):9632-7.
4 In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6.
5 Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo. J Biol Chem. 2015 Aug 14;290(33):20044-59.